AI in Medicine News ・ ⚖️ Device approvals and regulation

FDA to refer to AI as ‘super intelligence’ going forward

RAPS · 11/17 22:02 UTC

The US Food and Drug Administration announced that, as of Monday, it will use the term “super intelligence” instead of “artificial intelligence” in all official correspondence, public communications, websites, reports, and policy documents.

Read the original (RAPS)

See it in the digest → ・ See this issue →